Discovery and Characterization of a Novel MASTL Inhibitor MKI-2 Targeting MASTL-PP2A in Breast Cancer Cells and Oocytes

Although microtubule-associated serine/threonine kinase-like (MASTL) is a promising target for selective anticancer treatment, MASTL inhibitors with nano range potency and antitumor efficacy have not been reported. Here, we report a novel potent and selective MASTL inhibitor MASTL kinase inhibitor-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Minsung, Kim, Chijung, Leem, Jiyeon, Kim, Ye-hyun, Kwon, Young-ju, Yoon, Yi Na, Chae, Chong Hak, Ahn, Jiyeon, Jung, Kwan-Young, Oh, Jeong Su, Kim, Jae-Sung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308786/
https://www.ncbi.nlm.nih.gov/pubmed/34358073
http://dx.doi.org/10.3390/ph14070647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308786/
https://www.ncbi.nlm.nih.gov/pubmed/34358073
http://dx.doi.org/10.3390/ph14070647

Ejemplares similares